This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

GSK urges Third Circuit to block Louisiana antitrust case over Flonase

( October 26, 2016, 22:31 GMT | Official Statement) -- MLex Summary: GlaxoSmithKline has filed an opening brief in its appeal of a decision that allowed the state of Louisiana to bring allegations that the drugmaker delayed the market entry of generic Flonase. GSK says that sovereign does not immunize the state from a settlement to which it was a party. “Sovereign immunity does not apply when, as here, the state is aligned solely as a plaintiff, i.e., no one asserts any claim against the state,” wrote GSK. See document below. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections